Article
[Effect of EGFR-TKI on lymphangiogenesis of lung cancer with EGFR mutation].
Zhongguo fei ai za zhi = Chinese journal of lung cancer - 1 Dec 2014
Cai Minghui, Yang Xinying, Jiang Baohong, Teng Fukang, Pan Yan, Mao Feng, Shen-Tu Yang
Abstract excerpt
BACKGROUND AND OBJECTIVE: This study aims to explore the effect of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKIs) on the lymphangiogenesis of lung cancer with EGFR mutation, as well as to determine the function of EGFR targeted therapy in relation to the inhibition of lymp...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
